BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31335430)

  • 1. An Atypical Fibroxanthoma and Intradermal Nevus Collision Tumor-Potential for Misdiagnosis.
    Steel A; Debbaneh M; Cassarino D
    Am J Dermatopathol; 2019 Aug; 41(8):e87-e89. PubMed ID: 31335430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell atypical fibroxanthoma:a clinicopathologic study.
    Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
    J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell atypical fibroxanthoma: a case report and review of the literature.
    Nguyen CM; Chong K; Cassarino D
    J Cutan Pathol; 2016 Jun; 43(6):538-542. PubMed ID: 26956561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma within an intradermal nevus.
    Tajima Y; Nakajima T; Sugano I; Nagao K; Kondo Y
    Am J Dermatopathol; 1994 Jun; 16(3):301-6. PubMed ID: 7943639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplastic melanoma with sarcomatoid dedifferentiation.
    Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
    Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
    Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
    Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudolymphomatous Atypical Fibroxanthoma.
    Garcia Castro R; Viñolas-Cuadros A; Moyano-Bueno D; Conde-Ferreiros A; Cardeñoso E; Santos-Briz A
    Am J Dermatopathol; 2020 Dec; 42(12):972-976. PubMed ID: 32769551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Fibroxanthoma.
    Chapman LW; Yu SS; Arron ST
    Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
    Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
    Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoma-like tumor of head and neck skin.
    Nonaka D; Bishop PW
    Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
    Miller K; Goodlad JR; Brenn T
    Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MITF positivity in atypical fibroxanthoma: a diagnostic pitfall.
    Tallon B; Beer TW
    Am J Dermatopathol; 2014 Nov; 36(11):888-91. PubMed ID: 25238448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibroblastic differentiation in atypical fibroxanthomas occurring on sun-exposed skin and in a burn scar: an ultrastructural and immunohistochemical study.
    Ito A; Yamada N; Yoshida Y; Morino S; Yamamoto O
    J Cutan Pathol; 2011 Aug; 38(8):670-6. PubMed ID: 21623865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxoid atypical fibroxanthoma: a previously undescribed variant.
    Patton A; Page R; Googe PB; King R
    J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
    Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
    Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature With Special Emphasis on the Differential Diagnosis.
    Tardío JC; Pinedo F; Aramburu JA; Martínez-González MÁ; Arias D; Khedaoui R; Suárez-Massa D; Santonja C
    Am J Dermatopathol; 2016 Aug; 38(8):586-92. PubMed ID: 26848640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.